A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients’ modifiable risk factor profile
Authors:
Open Access
- 7 August 2008
- journal article
- research article
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 62 (10) , 1484-1498
Abstract
We assessed whether a novel programme to evaluate/communicate predicted coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk vs. usual care. The Risk Evaluation and Communication Health Outcomes and Utilization Trial was a prospective, controlled, cluster-randomised trial in nine European countries, among patients at moderate cardiovascular risk. Following baseline assessments, physicians in the intervention group calculated patients' predicted CHD risk and were instructed to advise patients according to a risk evaluation/communication programme. Usual care physicians did not calculate patients' risk and provided usual care only. The primary end-point was Framingham 10-year CHD risk at 6 months with intervention vs. usual care. Of 1103 patients across 100 sites, 524 patients receiving intervention, and 461 receiving usual care, were analysed for efficacy. After 6 months, mean predicted risks were 12.5% with intervention, and 13.7% with usual care [odds ratio = 0.896; p = 0.001, adjusted for risk at baseline (17.2% intervention; 16.9% usual care) and other covariates]. The proportion of patients achieving both blood pressure and low-density lipoprotein cholesterol targets was significantly higher with intervention (25.4%) than usual care (14.1%; p < 0.001), and 29.3% of smokers in the intervention group quit smoking vs. 21.4% of those receiving usual care (p = 0.04). A physician-implemented CHD risk evaluation/communication programme improved patients' modifiable risk factor profile, and lowered predicted CHD risk compared with usual care. By combining this strategy with more intensive treatment to reduce residual modifiable risk, we believe that substantial improvements in cardiovascular disease prevention could be achieved in clinical practice.Keywords
This publication has 68 references indexed in Scilit:
- Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trialThe Lancet, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trialInternational Journal of Cardiology, 2007
- Prediction of first coronary events with the Framingham score: A systematic reviewAmerican Heart Journal, 2007
- Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trialsHeart, 2007
- Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physiciansEuropean Journal of Preventive Cardiology, 2007
- Prevalence, Treatment, and Control of Combined Hypertension and Hypercholesterolemia in the United StatesThe American Journal of Cardiology, 2006
- Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medicationsInternational Journal Of Clinical Practice, 2005
- Hypertension Treatment and Control in Five European Countries, Canada, and the United StatesHypertension, 2004
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990